SCHEMBL4562682

SCHEMBL4562682

NC(=O)OC1CCN(Cc2ccn3ncnc(Nc4ccc(O)c(Cl)c4)c23)CC1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 18/20 0.62
▸ ERBB2 P04626 17/20 0.62
▸ LCK P06239 2/20 0.62
▸ KDR P35968 1/20 0.62
▸ AAK1 Q2M2I8 3/20 0.51
▸ CIT O14578 1/20 0.51
▸ CHEK1 O14757 1/20 0.51
▸ GAK O14976 1/20 0.51
▸ STK10 O94804 1/20 0.51
▸ PRKD3 O94806 1/20 0.51
▸ ABL1 P00519 1/20 0.51
▸ FYN P06241 1/20 0.51
▸ YES1 P07947 1/20 0.51
▸ LYN P07948 1/20 0.51
▸ RET P07949 1/20 0.51
▸ HCK P08631 1/20 0.51
▸ SRC P12931 1/20 0.51
▸ PHKG2 P15735 1/20 0.51
▸ PRKCA P17252 1/20 0.51
▸ PRKACA P17612 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6099658 0.85 EGFR (0.61) EGFRERBB2LCKKDRAAK1
SCHEMBL1220394 0.80 EGFR (0.71) EGFRERBB2LCKKDRAAK1
SCHEMBL1220440 0.80 EGFR (0.71) EGFRERBB2LCKKDRAAK1
SCHEMBL1220396 0.80 EGFR (0.71) EGFRERBB2LCKKDRAAK1
SCHEMBL1218828 0.79 EGFR (0.84) EGFRERBB2LCKKDRAAK1
SCHEMBL3553531 0.77 EGFR (0.81) EGFRERBB2LCKKDRAAK1
SCHEMBL3554356 0.77 EGFR (0.71) EGFRERBB2LCKKDRAAK1
SCHEMBL1219457 0.77 EGFR (1.00) EGFRERBB2LCKKDRAAK1
SCHEMBL1220093 0.77 EGFR (0.83) EGFRERBB2LCKKDRAAK1
SCHEMBL1220849 0.76 EGFR (1.00) EGFRERBB2LCKKDRAAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1699798-A4 DI-SUBSTITUTED PYRROLOTRIAZINE COMPOUNDS BRISTOL MYERS SQUIBB CO (US) 2009-03-11 — — EP disclosed
EP-1699798-A2 DI-SUBSTITUTED PYRROLOTRIAZINE COMPOUNDS Bristol-Myers Squibb Company (US) 2006-09-13 — — EP disclosed
WO-2005065266-A2 DI-SUBSTITUTED PYRROLOTRIAZINE COMPOUNDS BRISTOL-MYERS SQUIBB COMPANY (US) 2005-07-21 — — WO disclosed
Send feedback